At TechCrunch Early Stage, Y Combinator's Dalton Caldwell shared insights on the application process — what works on an application, what doesn't, and the right ways to stand out.
Late last year, Solugen, a startup using synthetic biology to take hydrocarbons out of the chemicals industry, decided against pursuing a new round of funding that would have valued the company at ove
In a deal that has potentially big implications for the sustainability of consumer packaged goods, biomaterial manufacturing technology developer Genomatica and the massive nylon material manufacturer
Now’s the time for sustainable investments to shine. There are billions of dollars in funding in both public and private markets dedicated to new sustainable investing and demand for consumers f
Justin Kan and Robin Chan have each been angel investing for more than a decade. They’re starting a new fund together now, though, to stay involved as cofounders of more startups. Goat Capital is a
There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies. Perhaps the most public (and tastiest) example of the promi
It will take until 2085 for Black workers to reach the same hiring rate of white men in the industry today. For Latinos, it will take until 2045. And for women, it will take until 2070.
Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the pharmaceuti
Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between. Today, the last day of 2019, we’re taking a second look at Boston. Regular
In this week's newsletter: Airbnb, WeWork and Postmates prep IPOs.
Ginkgo Bioworks is now worth $4 billion after a $290 million capital infusion that will give the company the cash to dramatically expand its developer shop for genetic programming. The Boston-based co
As biotechnology becomes more central to new innovations in healthcare, material science and manufacturing, one of the nation’s research hubs is getting a new accelerator called Petri to launch
Much of Silicon Valley mythology is centered on the founder-as-hero narrative. But historically, scientific founders leading the charge for bio companies have been far less common.
Jeff Ubersax knows yeast. The chief executive officer of Demetrix studied yeast genetics and biochemistry in school and was an early employee at Amyris Biotechnologies, a technology company that was u
We put together a list of venture funds operated by some of the larger food and beverage producers, covering literally everything from soup to nuts (plus lunch meat and soda, too!).
A look at the 20 most successful companies to come out of Y Combinator.
Boston biotech startup Ginkgo Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility. The funding comes from previous investors Viking Glo
Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes craz
Ginko Bioworks, the Boston-based biotech startup making all sorts of scents and flavors from microbugs, has pulled in $100 million in Series C funding to obtain 600 million base pairs of manufactured
Boston biotech startup Ginkgo Bioworks just gained an extra $45 million in Series B funding from an "oversubscribed" list of investors. The startup raised $9 million in March, so that gives the startu
Load More